Phase 1/2 Randomized Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Pleural Mesothelioma-NCT03126630
JOURNAL OF THORACIC ONCOLOGY(2023)
关键词
Mesothelioma,PD-1,antibody-drug conjugate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要